Sanofi Share Price

Equities

SAN

FR0000120578

Pharmaceuticals

Market Closed - Euronext Paris 16:35:19 24/06/2024 BST After market 19:59:19
90.36 EUR +3.13% Intraday chart for Sanofi 90.77 +0.45%

Financials

Sales 2024 * 46.34B 49.74B 3,921B Sales 2025 * 49.89B 53.55B 4,221B Capitalization 110B 118B 9,269B
Net income 2024 * 7.07B 7.59B 599B Net income 2025 * 8.68B 9.32B 735B EV / Sales 2024 * 2.51 x
Net Debt 2024 * 6.92B 7.43B 586B Net Debt 2025 * 2.31B 2.48B 195B EV / Sales 2025 * 2.24 x
P/E ratio 2024 *
15.8 x
P/E ratio 2025 *
12.7 x
Employees 86,088
Yield 2024 *
4.42%
Yield 2025 *
4.65%
Free-Float 87.13%
More Fundamentals * Assessed data
Dynamic Chart
1 day+3.13%
1 week+3.07%
Current month+0.67%
1 month+0.94%
3 months+0.79%
6 months+1.33%
Current year+0.67%
More quotes
1 week
86.71
Extreme 86.71
90.79
1 month
85.94
Extreme 85.94
91.73
Current year
84.93
Extreme 84.93
96.50
1 year
80.60
Extreme 80.6
104.32
3 years
76.45
Extreme 76.45
106.66
5 years
67.65
Extreme 67.65
106.66
10 years
62.50
Extreme 62.5
106.66
More quotes
Managers TitleAgeSince
Chief Executive Officer 56 31/08/19
Chief Operating Officer 40 31/12/21
Chief Tech/Sci/R&D Officer 51 -
Members of the board TitleAgeSince
Director/Board Member 70 30/04/14
Director/Board Member 62 27/04/20
Director/Board Member 64 21/05/20
More insiders
Date Price Change Volume
24/06/24 90.36 +3.13% 2 067 170
21/06/24 87.62 -0.56% 5,019,503
20/06/24 88.11 +1.49% 1,373,951
19/06/24 86.82 -1.91% 1,116,660
18/06/24 88.51 +0.96% 1,427,286

Real-time Euronext Paris, June 24, 2024 at 04:35 pm

More quotes
Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows: - pharmaceutical products (70.6%): prescription drugs in the areas of specialty medicine (59.3% of net sales; for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases) and general medicine (40.7%; mainly for the treatment of diabetes and cardiovascular diseases); - human vaccines (17.4%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas; - consumer health products (12%). At the end of 2023, the group had 54 production sites throughout the world. Net sales are distributed geographically as follows: France (5.5%), Europe (18.6%), the United States (43%), North America (1.6%) and other (31.3%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
87.62 EUR
Average target price
108.2 EUR
Spread / Average Target
+23.48%
Consensus